(IBDS) iBonds Dec 2027 Term - Overview
ETF Category: Target Maturity | Exchange NYSE ARCA (USA) | Currency USD | Market Cap: 3.754m | Total Return 4.7% in 12m
Etf: Corporate Bonds, Investment Grade, Fixed Income
Total Rating 37
Risk 69
Buy Signal -0.25
| Risk 5d forecast | |
|---|---|
| Volatility | 1.51% |
| Relative Tail Risk | -7.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.21 |
| Alpha | -0.20 |
| Character TTM | |
|---|---|
| Beta | 0.039 |
| Beta Downside | -0.003 |
| Drawdowns 3y | |
|---|---|
| Max DD | 2.99% |
| CAGR/Max DD | 1.73 |
Description: IBDS iBonds Dec 2027 Term March 05, 2026
IBDS is an exchange-traded fund that invests primarily in U.S. dollar-denominated, investment-grade corporate bonds. These bonds mature in 2027.
The funds investment strategy focuses on replicating an underlying index, with at least 80% of assets in index components and 90% in fixed-income securities represented in the index. Corporate bonds are debt instruments issued by companies to raise capital.
For more detailed analysis of IBDS and similar investments, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- Interest rate hikes depress corporate bond prices
- Credit rating downgrades increase default risk
- Inflation erodes fixed income purchasing power
- Corporate earnings impact bond issuer stability
What is the price of IBDS shares?
As of March 25, 2026, the stock is trading at USD 24.17 with a total of 373,188 shares traded.
Over the past week, the price has changed by -0.12%, over one month by -0.31%, over three months by +0.33% and over the past year by +4.65%.
Over the past week, the price has changed by -0.12%, over one month by -0.31%, over three months by +0.33% and over the past year by +4.65%.
Is IBDS a buy, sell or hold?
iBonds Dec 2027 Term has no consensus analysts rating.
What are the forecasts/targets for the IBDS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |